{
    "eid": "2-s2.0-85143619389",
    "title": "3\u2032,4\u2032,5\u2032-trimethoxy- and 3,4-dimethoxychalcones targeting A549 cells: Synthesis, cytotoxic activity, and molecular docking",
    "cover-date": "2023-03-05",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Spectroscopy",
            "@code": "1607",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Inorganic Chemistry",
            "@code": "1604",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [],
    "authors": [
        "Ade Danova",
        "Duy Vu Nguyen",
        "Riho Toyoda",
        "Panupong Mahalapbutr",
        "Thanyada Rungrotmongkol",
        "Piyanuch Wonganan",
        "Warinthorn Chavasiri"
    ],
    "citedby-count": 0,
    "ref-count": 54,
    "ref-list": [
        "Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries",
        "Molecular pathogenesis of lung cancer",
        "Epidermal growth factor receptor targeting in cancer: a review of trends and strategies",
        "The epidermal growth factor receptor and its inhibition in cancer therapy",
        "Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains",
        "Gefitinib or chemotherapy for non\u2013small-cell lung cancer with mutated EGFR",
        "Review of erlotinib in the treatment of advanced non-small cell lung cancer",
        "BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models",
        "Osimertinib in untreated EGFR-mutated advanced non\u2013small-cell lung cancer",
        "Characteristics of lung cancers harboring NRAS mutations",
        "Acquired EGFR C797S mutation mediates resistance to AZD9291 in non\u2013small cell lung cancer harboring EGFR T790M",
        "Acquired resistance of EGFR-mutant lung cancer to a T790M-specific EGFR inhibitor: emergence of a third mutation (C797S) in the EGFR tyrosine kinase domain",
        "Synthesis and anti-proliferative activity of some new quinoline based 4, 5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors",
        "Structure\u2013activity relationship of antibacterial chalcones",
        "Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted",
        "Synthesis and cytotoxic, anti-inflammatory, and anti-oxidant activities of 2\u2032,5\u2032-dialkoxylchalcones as cancer chemopreventive agents",
        "Synthesis and biological evaluation of 3\u2032,4\u2032,5\u2032-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation",
        "Chalcones in cancer: understanding their role in terms of QSAR",
        "A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome",
        "Anticancer activities of novel chalcone and bis-chalcone derivatives",
        "Design, synthesis, and evaluation of novel boronic-chalcone derivatives as antitumor agents",
        "Chalcones: a new class of antimitotic agents",
        "Synthesis and investigations into the anticancer and antibacterial activity studies of \u03b2-carboline chalcones and their bromide salts",
        "Structure\u2212activity relationship studies of chalcone leading to 3-hydroxy-4,3\u2032,4\u2032,5\u2032-tetramethoxychalcone and Its analogues as potent nuclear factor \u03baB Inhibitors and their anticancer activities",
        "Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents",
        "The synthesis and angiotensin converting enzyme (ACE) inhibitory activity of chalcones and their pyrazole derivatives",
        "The interaction of chalcones with tubulin",
        "Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity",
        "Synthesis of chalcone-amidobenzothiazole conjugates as antimitotic and apoptotic inducing agents",
        "Biological evaluation and molecular dynamics simulation of chalcone derivatives as epidermal growth factor-tyrosine kinase inhibitors",
        "Diverse Molecular Targets for Chalcones with Varied Bioactivities",
        "Isoliquiritigenin induces apoptosis and inhibits xenograft tumor growth of human lung cancer cells by targeting both wild type and L858R/T790M mutant EGFR",
        "The potent anti-tumor-promoting agent isoliquiritigenin",
        "Anticancer activity of ruthenocenyl chalcones and their molecular docking studies",
        "Synthesis and cytotoxicity evaluation of biaryl-based chalcones and their potential in TNF\u03b1-induced nuclear factor-\u03baB activation inhibition",
        "Colchicine site inhibitors of microtubule integrity as vascular disrupting agents",
        "Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4",
        "Synthesis and biological evaluation of Combretastatin A-4 derivatives containing a 3\u2019-O-substituted carbonic ether moiety as potential antitumor agents",
        "Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents",
        "Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin",
        "Design, synthesis, and biological evaluation of thiophene analogues of chalcones",
        "Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors",
        "Synthesis of \u03b1, \u03b2-unsaturated carbonyl-based compounds, oxime and oxime ether analogs as potential anticancer agents for overcoming cancer multidrug resistance by modulation of efflux pumps in tumor cells",
        "Design, synthesis and cytotoxic evaluation of novel chalcone derivatives bearing triazolo [4, 3-a]-quinoxaline moieties as potent anticancer agents with dual EGFR kinase and tubulin polymerization inhibitory effects",
        "Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1, 4-dihydroindeno [1, 2-c] pyrazole chalcone as EGFR/Akt pathway inhibitors",
        "Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors",
        "Mechanisms and insights into drug resistance in cancer",
        "Synthesis and characterization of chalcone-pyridinium hybrids as potential anti-cancer and anti-microbial agents",
        "Tetrahydroxanthone\u2013chromanone heterodimers from lichen Usnea aciculifera and their cytotoxic activity against human cancer cell lines",
        "Atomistic mechanisms underlying the activation of the G protein-coupled sweet receptor heterodimer by sugar alcohol recognition",
        "Enhanced solubility and anticancer potential of Mansonone G by \u03b2-cyclodextrin-based host-guest complexation: a computational and experimental study",
        "Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Gifu",
            "@id": "60171713",
            "affilname": "Graduate School of Natural Science and Technology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60171713",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}